Neutron Capture Therapy in Support of Other Radiation Treatment
Neutron capture therapy (NCT) appears potentially useful, not only as a treatment modality per se, but also as an adjuvant in the context of established clinical measures to control pathological growth. Since the probability of local control is a steep function of absorbed dose, even a modest specific exposure of neoplasms by such techniques would significantly increase the chances of cure. Such a prospect seems most natural in fast neutron therapy 1,2,3 where slow neutrons are automatically available in the target area. As a promising alternative, it would be possible to combine the use of protons or heavier ions with a booster therapy based on boron compounds and intermediate-energy neutrons.4 Such a situation would be particularly relevant when there are needs both for the precision of heavy charged-particle beams--permitting tailored 3-dimensional dose plans for the treatment of structures visible by computerized imaging methods--and for the particular features of NCT that also aim at eradication of invisible but suspected microsopic growth in larger anatomical regions.
KeywordsStarch Boron Radionuclide Macromolecule Porphyrin
Unable to display preview. Download preview PDF.
- 2.B. Larsson, Boron in fast neutron therapy? Implications of present research with slow neutrons, Strahlentherapie 160: 129 (1984).Google Scholar
- 3.V. Lorvidhaya, S. Na Chiangmai, T. Vilaithong, S. Wanwilairat, N. Chawapun, O. Sornsuntisook, W. Wangpreedalertkul, Y. Anusri, and B. Larsson, Neutron treatment of cervical carcinoma - an experimental approach, Paper No. 15–6 presented at the 3rd Int. Conf. on Neutron Capture Therapy, Bremen, FRG, 1988.Google Scholar
- 4.H. Conde, E. Grusell, B. Larsson, E. Ramstrom, T. Ronnqvist, O. Sornsuntisook, S. Villa, J. Crawford, H. Reist, B. Dahl, and N. G. Sjostrand, Status report on the development of a spallation neutron source for neutron capture therapy, in: “Proc. of Workshop on Neutron Capture Therapy”, Brookhaven, 1988, in press.Google Scholar
- 7.B. Larsson, Labelled macromolecules for studies of cellular receptors in vivo, Medical Applications of Cyclotron III, Ann. Univ. Turkuensis D: 17: 87 (1987).Google Scholar
- 8.B. Larsson, O. Sornsuntisook, G. Ericson, E. Johansson, K. Skold, B. Nilsson, and M. Fantini, Neutron microradiography for cell-seeking boron compounds, in: “Neutron Radiography”, Proc. 2nd World Conf., D. Riedel, ed., Paris (1986) p. 497.Google Scholar
- 9.J. Carlsson, G. Ericson, E. Grusell, B. Larsson, G. Possnert, F. Wikstrom, S. Na Chiangmai, O. Sornsuntisook, B. Stenerlov, and P. Stromberg, Developments in microradiography of charged particle tracks. Paper No. 9–5, presented at the 3rd Int. Conf. on Neutron Capture Therapy, Bremen, FRG, 1988.Google Scholar
- 11.D. Gabel, R. G. Fairchild, B. Larsson K. Drescher, and W. R. Rowe, The bioloical effect of the 10B(n,a)7Li reaction and its simulation by Monte Carlo calculations, in: “Proceedings of 1st Int. Symp. on Neutron Capture Therapy”, R.G. Fairchild and G. L. Brownell,eds., U.S. Government Printing Office (1984) pp. 128–133.Google Scholar
- 12.J. Carlsson and B. Larsson, Boron-loaded antibodies and slow neutrons: Status report from experiments on biological models II, Studies of antibody penetration in cellular spheroids, in: “Neutron Capture Therapy”, ed. H. Hatanaka, Nishimura Co. Ltd., Niigata (1985), p. 359.Google Scholar
- 13.B. Larsson, J.Carlsson, H. Borner, J. Forsberg, A. Fourcy, and M. Thellier, Biological studies with cold neutrons, An experimental approach to the LET problem in radiotherapy, in: “Progress in Radio-oncology II”, ed. R. H. Karcher, Raven Press, New York (1982), p. 151.Google Scholar
- 14.L. E. Lorelius, A. R. Benedetto, R. Blumhardt, H. W. Gaskill, J. L. Lancaster, and H. Stridbeck, Enhanced Drug Retention in VX2 Tumours by use of Degradable Starch Microspheres, Inv. Radiology, 19: 212–5 (1984).Google Scholar